The biopharma sector has been quite surreal lately, with LABU and XBI starting to skid again. The news keeps pushing big industry deals every day, but then leading stock Moderna withdrew a filing, directly cooling down sector sentiment. The volatility index of the triple-long LABU went off the charts. Sometimes I really feel that chasing these high-Beta ETFs is like riding a roller coaster; you might not get the red envelope, but getting dizzy is for real. Faith and drawdowns keep swinging back and forth, making me feel like an old naive investor, unsure whether to average down or just watch the show with a zen attitude.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
